Email Newsletters

New president for drug company

Branford-based Neurogen Corp. appointed Stephen R. Davis president, effective immediately. William H. Koster, previously president and CEO, will remain as CEO of the company, though Davis has been selected as his future successor. Previously, Davis, who has been with the company since 1994, was executive vice president and COO. He has also held positions with Milbank, Tweed, Hadley and McCloy and Aurthur Anderson & Co. Davis has a B.S. in accounting from Southern Nazarene University and a J.D. from Vanderbilt University.

Learn more about:
– Digital Partners -

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA